Showing 12 of 12 recruiting trials for “Gliosarcoma”
A Study Assessing if it is Safe and Possible to Treat Brain Cancer Patients With Immunotherapy Before They Receive the Standard Treatment.
Intrathecal Azacitidine and Nivolumab in Patients With Recurrent High-grade Glioma
Study of ABBV-637 or ABBV-155 With ERAS-801 for People With Glioblastoma
👨⚕️ Thomas Kaley, MD, Memorial Sloan Kettering Cancer Center📍 10 sites📅 Started Apr 2025View details ↗
RecruitingNCT05756985 ↗
Improving Understanding of Glioblastoma Through Preservation of Biologically Active Brain Tissue
👨⚕️ Manmeet S Ahluwalia, M.D., Miami Cancer Institute at Baptist Health, Inc.📍 1 site📅 Started Dec 2024View details ↗
Phase 2a Immune Modulation With Ultrasound for Newly Diagnosed Glioblastoma
RecruitingNCT06954636 ↗
Prognostic Potential of Olfactory Function in Glioblastoma: a Prospective Observational Study
Phase I CB-NK-TGF-ßR2-/NR3C1- in rGBM
Intracavitary Photodynamic Therapy as an Adjuvant to Resection of Glioblastoma or Gliosarcoma Using IV Photobac®
Ex Vivo Drug Sensitivity Testing and Multi-Omics Profiling
Efineptakin Alfa and Pembrolizumab for the Treatment of Recurrent Glioblastoma
hSTAR GBM (Hematopoetic Stem Cell (HPC) Rescue for GBM)
👨⚕️ Leland Metheny, MD, University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center📍 1 site📅 Started Jan 2023View details ↗
Atezolizumab and Cabozantinib for the Treatment of Recurrent Glioblastoma
Get alerts when new trials open
Create a free account to follow conditions and receive trial notifications.
Create free account →